October 30, 2020
Shardul Amarchand Mangaldas & Co (SAM & Co) advised Kotak Mahindra Capital Company Limited, Axis Capital Limited, Citigroup Global Markets India Private Limited, DSP Merrill Lynch Limited, ICICI Securities Limited, JM Financial Limited, SBI Capital Markets Limited, Investec Capital Services (India) Private Limited, JM Financial Services Limited, Kotak Securities Limited and SBICAP Securities Limited (collectively, the ‘Underwriters’), in the initial public offering of the equity shares of UTI Asset Management Company Limited through an offer for sale by State Bank of India, Life Insurance Corporation of India, Punjab National Bank and Bank of Baroda and T. Rowe Price International Ltd. The deal is valued at USD 295 million (approx.) The date of listing was October 12, 2020.
The transaction team was led by Prashant Gupta, National Practice Head, Nikhil Naredi, Partner, and Monal Mukherjee, Partner comprised Sagarnil Banerjee, Principal Associate, Devesh K., Senior Associate, Chinmay Sethia, Associate, and Tarun Srikanth, Associate.
Cyril Amarchand Mangaldas, Mumbai advised UTI Asset Management Company Limited; Cravath, Swaine & Moore LLP advised the BRLMs as to U.S. Securities Law; Khaitan & Co. advised State Bank of India, Life Insurance Corporation of India, Punjab National Bank and Bank of Baroda and T. Rowe Price International Ltd.
The Bar Council of India does not permit solicitation of work and advertising by legal practitioners and advocates. By accessing the Shardul Amarchand Mangaldas & Co. website (our website), the user acknowledges that:
Click here for important public notice from the Firm.